Pricing Log in Create free account

Atossa Therapeutics, Inc. (ATOS) vs IGC Pharma, Inc. (IGC)

Atossa Therapeutics, Inc. and IGC Pharma, Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and IGC Pharma, Inc. are of similar size ($26.4M and $26.3M). IGC Pharma, Inc. grew revenue faster over the last twelve months: −13.4% against −93.7%. Atossa Therapeutics, Inc. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−3,918.8% vs −91.5%). Across the 17 metrics below, Atossa Therapeutics, Inc. leads on 9 and IGC Pharma, Inc. on 8.

Valuation

Metric ATOS IGC Biotechnology median
P/E n/m n/m 8.50
P/S 646.51 22.78 9.71
P/B 0.97 4.09 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.01 n/m 0.64
EV/Sales (6.95) 23.44 9.21
Earnings yield (150.60%) (36.00%) (33.15%)
Free cash flow yield (138.09%) (22.67%) (25.50%)

Profitability

Metric ATOS IGC Biotechnology median
Gross margin 0.00% 32.33% 65.16%
Operating margin 0.00% (912.44%) 0.00%
Net margin 0.00% (795.46%) 0.00%
Free cash flow margin 0.00% (516.53%) 0.00%
Return on equity (89.23%) (143.46%) (56.36%)
Return on assets (77.91%) (100.44%) (48.04%)
Return on invested capital (3,918.83%) (91.53%) 0.00%

Growth

Metric ATOS IGC Biotechnology median
Revenue growth (TTM) (93.66%) (13.38%) 6.02%
EPS growth (last fiscal year) (34.73%) 57.85% 30.26%
Revenue growth, 5-year CAGR — (20.77%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS IGC Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 5.69 0.39 4.72
Net debt to EBITDA 1.12 0.04 0.96

Dividend

Metric ATOS IGC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATOS IGC Biotechnology median
Market cap 26.44m 26.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack